Most lately, it's been recognized that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in comparable parts as classical opioid receptors, it binds to the big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger and won't activate a 2nd messenger m… Read More